Synapse
⌘+K
Synapse
PulseExploreJournal ClubResearchersJournals
Instagram
HomeJournal ClubExplore
October 1, 2025

A retrospective study on triggering factors and management of epistaxis - our experience in a tertiary ENT clinic.

View Full Paper
Ask AI
Bookmark
Share

Authors

RPRaluca Oana PulpăRARuxandra Oana AliușARAndreea Rusescu

Discussion

Loading...

Member takes

Overview

Retrospective study examined epistaxis triggers in 1,173 patients, revealing hypertension and anticoagulant therapy as key factors.

Key Points

  • Hypertension and anticoagulant therapy were identified as the most common triggers of epistaxis, emphasizing the need for careful management.
  • Among the 1,173 patients studied, 38.46% of epistaxis cases were idiopathic, highlighting the complexity of its etiology.
  • Most anterior nasal bleedings responded well to conservative measures, but severe cases necessitated surgical interventions.
  • Proper management, including control of cardiovascular comorbidities, may significantly reduce recurrence and complications associated with epistaxis.

Cite This Study

Pulpă et al. (2025) studied this question.

synapsesocial.com/papers/68dd89e6fe798ba2fc497f01https://doi.org/10.25122/jml-2025-0107
View Full Paper
Ask AI
Bookmark
Share